SecBot SecBot
Insider Cluster (3 insiders) ·Filed Apr 24, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 3/10
Horizonimmediate Processed6mo ago
Insider cluster: 3 insiders, $1.8M total
Actionable Insight • Neutral

Insider selling is trivial and likely for personal diversification or tax planning. No immediate action warranted; monitor for any subsequent material filings.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$566.99
T+0 close · Apr 24, 2026 · via day close
Latest settled
−6.61%
T+60 · $529.53
Vs SPY
−9.82%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 27 $566.99entry
  2. T+1 · 7mo ago +0.37%α +0.86% · $569.11
  3. T+5 · 7mo ago +2.51%α +2.11% · $581.22
  4. T+20 · 6mo ago +2.02%α −2.94% · $578.43
  5. T+60 · 4mo ago −6.61%α −9.82% · $529.53
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three UTHR insiders (CEO, CFO, and a director) sold a total of ~$3.77M in open-market shares over a one-week period, representing less than 0.02% of the company's $25B market cap. These sales are routine and immaterial, with no bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$3.8M
Insiders
3

Key Facts

  • Total open-market sales by three insiders: ~$3.77M
  • Sales represent <0.02% of $25B market cap
  • CEO Rothblatt sold ~$989K, CFO Edgemond sold ~$1.12M, Director Patusky sold ~$1.66M
  • All sales are small relative to company size and insider holdings

Financial Impact

~$3.77M in insider sales, immaterial relative to market cap

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
76% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1777669039525

Track record

123 reports on UTHR

Performance horizon

4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
  2. Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
  3. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
  4. Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
  5. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  6. Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  7. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
  8. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  9. Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  10. Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
Showing 10 of 123

US Market Status

Market Closed · Opens Wed (10h 25m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 1, 2026